Long-term citrate anticoagulation for high-flux haemodialysis in a patient with heparin-induced thrombocytopenia type II.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Acta Medica Austriaca

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1563-2571.2002.02019.XPMID 12424942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simplified citrate anticoagulation for high-flux hemodialysis.

  2001cited by this paper
• Treatment of Hirudin Overdosage in a Patient with Chronic Renal Failure

  1999cited by this paper
• Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis.

  1998cited by this paper
• New CRRT systems: impact on dose delivery.

  1997cited by this paper
• Pharmacokinetics of Recombinant Hirudin in Hemodialyzed End-stage Renal Failure Patients

  1997cited by this paper
• Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.

  1996cited by this paper
• Heparin-induced thrombocytopenia in hemodialysis patients.

  1996cited by this paper
• Heparin‐induced thrombocytopenia: cross‐reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran)

  1995cited by this paper
• Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis.

  1994cited by this paper
• Low molecular weight heparin: a critical analysis of clinical trials.

  1994cited by this paper
• Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate.

  1993cited by this paper
• Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.

  1993cited by this paper
• Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.

  1992cited by this paper
• Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation.

  1987cited by this paper
• Severe metabolic alkalosis complicating regional citrate hemodialysis.

  1987cited by this paper
• Regional anticoagulation: hemodialysis with hypertonic trisodium citrate.

  1986cited by this paper
• REGIONAL ANTICOAGULATION DURING HEMODIALYSIS USING CITRATE

  1961cited by this paper
• Nephrology Dialysis Transplantation in Vitro Study of R-hirudin Permeability through Membranes of Different Haemodialysers

  year unknowncited by this paper

• Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges

  2016cites this paper
• Management of heparin-induced thrombocytopenia

  2012cites this paper
• Long‐Term Citrate Anticoagulation in Chronic Hemodialysis Patients

  2011cites this paper
• Regional citrate anticoagulation for hemodialysis: a safe and efficient method.

  2010cites this paper
• Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis.

  2010cites this paper
• Heparin-Induced Thrombocytopenia Treatment and Prevention of ull

  2008cites this paper
• Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Heparin-Induced Thrombocytopenia : Treatment and Prevention of

  2008cites this paper
• Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cites this paper
• (8th Edition) Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Heparin-Induced Thrombocytopenia: Treatment and Prevention of

  2008cites this paper
• Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients.

  2005cites this paper
• Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cites this paper
• Heparin‐induced thrombocytopenia during renal replacement therapy

  2004cites this paper
• Parathyroid Hormone Secretion During Citrate Anticoagulated Hemodialysis in Acutely Ill Maintenance Hemodialysis Patients

  2004cites this paper
• Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients.

  2004cites this paper
• Hemodialysis in Heparin-Induced Thrombocytopenia

  2003cites this paper
• Current Awareness: Pharmacoepidemiology and Drug Safety

  2003cites this paper
• Pharmacoepidemiology and drug safety.

  2003cites this paper